INTL, INTL FCStone Inc.

** On its fourth quarter fiscal 2011 results, INTL posted (Unaudited) total operating revenues of $108.1 million dollars, a 64% increase year over year while fiscal 2011 was a record year for the company in both adjusted operating revenues and adjusted net income.

IDRA, Idera Pharmaceuticals, Inc.

** IDRA reported that it has raised $9.5 million in a convertible preferred stock offering.